Showing results (1-10 of 875) with videos related to
Sort By:
Pageof 88
Journal of Alzheimer'S Disease : JAD|November 6, 2019
Alzheimer's Disease Progression in the 5×FAD Mouse Captured with a Multiplex Gene Expression ArrayAriana Gatt, David R Whitfield, Clive Ballard, et al.Translational Psychiatry|September 8, 2019
Drug repurposing for Alzheimer's disease based on transcriptional profiling of human iPSC-derived cortical neuronsGareth Williams, Ariana Gatt, Earl Clarke, et al.Neurobiology of Aging|February 5, 2019
Expression of neurogenic markers in Alzheimer's disease: a systematic review and metatranscriptional analysisAriana Gatt, Hyunah Lee, Gareth Williams, et al.Virus Research|September 28, 2020
Transcription-based drug repurposing for COVID-19Richard Killick, Clive Ballard, Patrick Doherty, et al.International Journal of Geriatric Psychiatry|June 2, 2018
Associations between ZnT3, tau pathology, agitation, and delusions in dementiaDavid R Whitfield, Paul T Francis, Clive Ballard, et al.Pharmaceuticals (Basel, Switzerland)|November 27, 2013
Drug repositioning: an opportunity to develop novel treatments for Alzheimer's diseaseAnne Corbett, Gareth Williams, Clive BallardFrontiers in Bioscience (Scholar Edition)|May 12, 2015
Drug repositioning in Alzheimer's diseaseAnne Corbett, Gareth Williams, Clive BallardBMC Bioinformatics|October 20, 2004
Inter-residue distances derived from fold contact propensities correlate with evolutionary substitution costsGareth Williams, Patrick DohertyCannabis and Cannabinoid Research|December 25, 2019
2-Linoleoylglycerol Is a Partial Agonist of the Human Cannabinoid Type 1 Receptor that Can Suppress 2-Arachidonolyglycerol and Anandamide ActivityLeanne Lu, Gareth Williams, Patrick DohertyScientific Reports|June 12, 2026
Retrospective case-control study of pre-diagnosis observational and prescription data in Parkinson's diseasePatrick Doherty, Susan Duty, Gareth WilliamsPageof 88